Current Rheumatology Reviews

Dr. Rossella De Angelis completed her MD degree in 1991 and specialization in Rheumatology in 1995. She further completed her PhD in Rheumatology and worked as a tenured researcher in Rheumatology. Dr. Angelis is currently an Associate Professor in Rheumatology at Polytechnic University of Marche, Italy. She is also the Head of the Inpatient Unit c/o Rheumatology Unit at Jesi Medical Center, Italy. She has over 100 publications, including original articles, abstracts and book chapters. Dr. Angelis's main research areas include Epidemiology of rheumatic diseases, Microcirculation in connective tissue diseases, Raynaud’s phenomenon, Nailfold capillary microscopy, Clinics in connective tissue diseases, Psoriatic arthritis, Seronegative spondyloarthritis. She has been an invited speaker at several Italian and International conventions.

Professor Marwan El Ghoch earned his doctorate in Medicine and Surgery from the University of Bologna, Italy, and postgraduate studies in Clinical Nutrition from the University of Modena and Reggio Emilia, Italy. He is an expert in obesity and eating disorders treatments, and developed an international leadership in the study of body composition in eating disorders and obesity. Currently cover the role of head of the Department of Nutrition and Dietetics at Beirut Arab University in Lebanon. Author of more than 100 papers published in high-ranking peer-review journals in the field of Medicine, Human Nutrition and Dietetics.

Professor Marwan El Ghoch MD earned his doctorate in Medicine and Surgery from the University of Bologna, Italy, and postgraduate studies in Clinical Nutrition from the University of Modena and Reggio Emilia, Italy. He is considered an expert in obesity and eating disorders treatments. Moreover he developed an international leadership in the study of the two-component model of body composition in anorexia nervosa. Currently cover the role of head of the Department of Nutrition and Dietetics at Beirut Arab University in Lebanon, and clinical investigator, at the Department of Eating and Weight Disorders at Villa Garda Hospital in Italy.

Dr. Sevdalina Lambova is a specialist in Internal Medicine and Rheumatology with PhD degree in Rheumatology. She is an Assistant Professor in Internal Medicine and Rheumatology in Medical University – Plovdiv, Bulgaria, Department of Propaedeutics of Internal diseases. Her main scientific interests are in the field of nailfold capillaroscopy, Raynaud’s phenomenon, systemic sclerosis, connective tissue diseases, osteoarthritis.

Dr Seza Özen is currently a Professor inthe Department of Pediatric Rheumatology at Hacettepe University, in Ankara, Turkey. She has graduated from the Medical School of Hacettepe University and had her Pediatrics training in the Department of Pediatrics at the same university. She did her post-doctoral fellowship in Stanford University School of Medicine and returned to her present department in 1990. Dr Özen has served as the Pediatric Chair in EULAR and as the president of the International Society for Autoinflammatory Diseases. She has published over 300 papers. Her main areas of intereset are autoinflamamtory diseases, vasculitis and lupus.

Ricard Cervera, MD, PhD, FRCP is Head of the Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Director of the Research Team on Systemic Autoimmune Diseases at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) of Barcelona, and Coordinator of the Masters’ on Autoimmune Diseases at the Universitat de Barcelona, Barcelona, Catalonia, Spain. He is also coordinator of the European Forum on Antiphospholipid Antibodies and of the European Working Party on Systemic Lupus Erythematosus (Euro-Lupus Group) and Chairman of the Lupus Academy. Dr. Cervera has presented over 400 invited lectures and has published more than 800 scientific papers (h index: 63), is co-editor of 30 books, and Associate Editor of the journals “Autoimmune Diseases” and “Lupus Science & Medicine”. His current major research interest includes clinical and epidemiological aspects of systemic autoimmune diseases, particularly systemic lupus erythematosus and the antiphospholipid syndrome, with special focus on its “catastrophic” variant.

Dr. De Martinis obtained his Degree in Medicine and Surgery and Specialization in Internal Medicine with honours from the University of L’Aquila, Italy. Currently, he is a Researcher - Aggregate Professor of Internal Medicine in the Department of Life, Health and Environmental Science, University of L’Aquila. He is a Lecturer of Internal Medicine, Haematology, Immunology in several First, Second and Specialization Degree Courses. He has authored several publications on relevant International Journals and chapters in books.

Prof Huizinga currently is chairman of Reumatology at Leiden University Medical Center, the oldest university of the Netherlands. He received his MD from the University of Amsterdam in 1986. He received his PhD cum laude in the biochemical and functional characterization of Fc-gamma Receptors in 1999. Since 2000, he has been appointed as a full professor. In 2006, he became the chairman of rheumatology in Leiden. His main interest is pathogenesis and treatment of rheumatoid arthritis and neuro-psychiatric SLE. He has (co)authored over 650 peer-reviewed articles. His H-factor is 81 and has been cited > 28.000 times and has written over 10 book chapters.

Dr. Meroni graduated from the University of Milan (1972). He got postgraduate training in clinical immunology in 1975, and haematology in 1979. He became the visiting fellow at the Laboratory of Immunopathology (Prof. I. Roitt), Middlesex Hospital, London (1979) and head of a Clinical Immunology & Rheumatology Unit, University Hospital in 1999. Since 2009, he has been serving as head of the Department of Rheumatology at the Orthopaedic Istituto G. Pini affiliated to the University of Milan, one of the largest rheumatology departments for adult and paediatric rheumatic diseases in Italy. Dr. Meroni has been the Chairman of the IUIS/WHO/AF/CDC Committee for the Standardization of Autoantibodies in Rheumatic and Related Diseases (2006-2012).

Dr Metyas is board certified in Internal Medicine and Rheumatology and has a Master’s Degree in orthopedic surgery. He has a private Rheumatology practice in Covina, CA. He is a Clinical Associate Professor of Rheumatology at the University of Southern California (USC), Chairman of Advocacy Committee of California Rheumatology Alliance and past-president of Southern California Rheumatology Society.Dr. Metyas has multiple publications in renowned peer review journals. He had presented multiple abstracts in the American College of Rheumatology meetings as well as the European Congress of Rheumatology .Dr. Metyas is a member of The Editorial Board of Current Rheumatology Reviews Journal and The Journal of Clinical Anesthesia and Management.

Dr. Mok is the head of the Division of Rheumatology, Department of Medicine, Tuen Mun Hospital. He is the past president of the Hong Kong Society of Rheumatology. His research interest is systemic lupus erythematosus and glucocorticoid-related osteoporosis. He has written more than 200 articles as the first author in top rheumatology and medical journals. Dr. Mok is on the editorial board of more than 15 rheumatology journals, and is a reviewer of more than 50 medical and rheumatology journals.

Jacques-Olivier Pers is the director of the INSERM research team ERI29 “Immunotherapy and B cell pathologies". He is involved since 1997 in the field of B cells in autoimmune diseases and lymphoproliferations. His studies have yielded 150 original articles and reviews which have contributed to improve the understanding of the characterization of B cell functions in autoimmunity and most particularly in Sjögren's syndrome and the contribution of BAFF to autoimmunity. His research group perpetuate the platform of immunopathology and immunotherapy dedicated to the study of normal and pathological B cells. He has studied different models such as autoimmune diseases (Sjögren’s syndrome, systemic lupus erythematosus, rheumatoid arthritis), lymphoproliferative disorders (chronic lymphocytic leukemia), kidney graft rejection and periodontal diseases from upstream approaches (epigenetics and autoimmunity, the genetic control of BAFF, calcium signaling, regulatory B cells) to downstream approaches (multicenter clinical trials, IVIg, valorization).

Dr. Ken Pritzker is currently the Chief Executive Officer, York Medtech Ventures Inc; CEO, Swan Cytologics Inc; Senior Advisor, Medical Director, Proteocyte Diagnostics Inc; Senior Advisor, Rna Diagnostics Inc. Dr. Pritzker is the Vice Chair, Board of Directors, Trillium Gift For Life Network. Dr. Pritzker is a Professor Emeritus in the Department of Laboratory Medicine and Pathobiology, Department of Surgery, and the Institute of Biomaterials and Biomedical Engineering, University of Toronto and Honorary Staff, Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto. Dr. Ken Pritzker has served as Chief, Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto from 1986 to 2008 and subsequently as founder of Mount Sinai Services.

Dr. Rampakakis has over 15 years of experience in scientific research, has contributed in the conception, design, analysis and interpretation of more than 80 large scale, national and international, registration and observational studies, and has contributed to 5 market approvals. He is an adjunct member of the department of pediatrics of McGill University and has numerous peer-reviewed publications at high impact scientific journals and presentations at international conferences. In addition, he serves as a reviewer for over five peer-reviewed journals, grant reviewer, and advisor for pharmaceutical, biotechnology, and cannabis companies.

Dr Renaudineau is a full professor, immunologist, and head of the laboratory of immunology and immunotherapy at the CHRU Morvan, Brest, France.Dr Renaudineau is member of the research team INSERM U1227 B lymphocytes and autoimmunity, of the European IMI project PRECISESADS (Molecular reclassification to find clinically useful biomarkers for systemic autoimmune diseases), of the labex IG0 (immunotherapy grand ouest), and of the epigenetic and ion channel networks from the canceropole grand ouest.Dr. Renaudineau's research interests include the role of B cells in the pathophysiology of autoimmune diseases including Sjögren's syndrome, systemic lupus erythematosus, rheumatoid arthritis and chronic lymphocytic leukemia, with a special focus on autoantibodies, CD5 molecule, calcium flux and DNA methylation due to their interconnections.

Dr. Zahi Touma is an assistant professor of medicine in the Division of Rheumatology at the University of Toronto, and a staff physician and clinician scientist in the Division of Rheumatology at Toronto Western Hospital and Mount Sinai Hospital. Dr Touma’s research includes outcome measurement, particularly for systemic lupus erythematosus and including assessment of lupus disease activity, cognitive function, classification and response criteria, and patient-reported outcomes.

Dr. Asiful Islam completed his PhD in genetics of antiphospholipid syndrome from Human Genome Centre, Universiti Sains Malaysia in 2018. Currently, he is working as a senior lecturer in the same university under the Department of Haematology. He has published around 34 (Web of Science-indexed) journal articles so far (total impact factor 2018: 107.057 citations: 554; h-index:13; i10-index: 16). He has been working as an academic editor for the journal PLOS ONE. His current major research interest includes haematological malignancies in autoimmune diseases.

Dr. Leila Itani graduated from the American University of Beirut in 1989 with an MSc degree in Nutrition and completed a PhD focusing on Nutrition education in 2018. She has a long teaching experience at different universities, as the Lebanese University and the Lebanese International University and worked at American University of Beirut as a research associate. She also served as the nutrition program coordinator at Lebanese International University. In addition, served as a co-consultant for the herbal and dietary supplement committee at the Lebanese Ministry of Health for several years. She joined the Beirut Arab University in 2010, and currently serving as an assistant professor at the Department of Nutrition and Dietetics in the Faculty of Health Sciences and actively involved in nutrition-related research and in the development of outreach nutrition education interventions in community service.

Dr. Heng Li received his B.S. from China Pharmaceutical University and earned his Ph.D. from University of Chinese Academy of Sciences. He is working as an assistant professor at Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China. He has been focusing on the innovative drug discovery and pharmacological mechanisms of refractory autoimmune diseases, especially IBD and skin inflammatory disorders. His previous research studies contributed to fully illustrating the pathological role of PDE4 in mucosal and skin inflammation and developing novel inhibitors in the treatment of immune disorders. As the first or corresponding author or co-author, he has published over 20 academic papers in SCI journals, including Br J Pharmacol, Cell Death Dis, and Cell Mol Immunol. He won several awards from Chinese Academy of Sciences, Chinese Pharmacological Society, and Shanghai Pharmacological Society. He serves as the reviewer of Eur J Pharmacol, Expert Opin Ther Targets, etc.